Caution Urged Regarding Warfarin Use
PHOENIX—The benefits of warfarin should be weighed against potential complications when used to treat atrial fibrillation (AF) in hemodialysis (HD) patients, according to British researchers.
Diagnosis & Disease Information
Data Support Intermittent Androgen Suppression
ORLANDO—Intermittent and continuous androgen suppression are associated with similar overall survival outcomes in men who have PSA progression after radiotherapy for prostate cancer (PCa), according to new data.
New Drug May Help Men with Hard-To-Treat Prostate Cancer
ORLANDO—An investigational drug called abiraterone acetate may improve the chances of survival among men with metastatic castration-resistant prostate cancer (CRPC) whose disease is progressing after receiving docetaxel-based chemotherapy, according to new findings.
Comorbidities Affect PCa Patient Death Risk
ORLANDO—Overall mortality among men with localized prostate cancer (PCa) increases with their burden of comorbid conditions, according to study findings presented at the fourth annual Genitourinary Cancers Symposium.
Imaging Guidelines for PCa Staging Often Not Followed
ORLANDO—Radiographic imaging studies often are used inappropriately for men with newly diagnosed prostate cancer (PCa), with certain patients undergoing unnecessary imaging and others not receiving imaging even though it is recommended, researchers concluded.
Pomegranate Extract May Slow Prostate Cancer Advance
ORLANDO—A pomegranate extract slowed progression of prostate cancer (PCa) in a study of men who had rising PSA levels after primary treatment for the malignancy.
Radiotherapy Benefits Men with Node-Positive PCa
ORLANDO—Radiotherapy for clinically staged node positive prostate cancer (PCa) is associated with improved PCa-specific and overall survival, according to investigators.
Drug Slows PCa Progression
ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer (PCa) progression in men undergoing active surveillance for the disease, researchers concluded.
Cytokine Found to Predict AKI Patient Outcomes
Osteopontin (OPN), a cytokine, may be a useful biomarker for predicting outcomes in critically ill patients with acute kidney injury (AKI), researchers reported.
Clot Breaker Reduces Hemodialysis Catheter Failure Risk
Use of recombinant tissue plasminogen activator (rt-PA) instead of heparin once weekly as a locking solution for central venous catheters in hemodialysis (HD) patients significantly decreases the risk of catheter malfunction and bacteremia compared with using heparin three times a week, according to Canadian researchers.
- Loading...
Loading...
Loading... 
Loading...